ENT Department, IRRCS San Raffaele Hospital, Vita-Salute University, via Olgettina 60, 20132, Milan, Italy.
Eur Arch Otorhinolaryngol. 2011 Apr;268(4):507-11. doi: 10.1007/s00405-010-1422-9. Epub 2010 Nov 11.
Even after successful repositioning maneuvers for benign paroxysmal positional vertigo (BPPV), some patients report dizziness lasting for a certain period afterwards. We studied the prevalence and clinical factors associated with residual dizziness in a sample of elderly patients. Sixty outpatients over 65 years of age, affected by idiopathic BPPV were recruited; the exclusion criterion was a history of previous episodes of vertigo, including positional. The patients were asked to describe their self-perceived anxiety for vertigo on a Visual Analogue Scale (VAS) and successively treated with appropriate maneuvers till resolution of nystagmus. Data concerning the demographic and clinical features of BPPV were collected. Patients were followed until complete resolution of subjective dizziness and imbalance without positional nystagmus. Data about residual dizziness were collected from the second day from resolution of BPPV. Clinical and demographic factors related to residual dizziness were analyzed. Twenty-two subjects (37%) reported residual dizziness. In these subjects, the mean duration of residual dizziness was 13.4 ± 7.5 days. No association was observed between residual dizziness and gender, involved canal and the number of repositioning maneuvers before resolution. On the other hand, age older than 72 years, symptom duration greater than 9 days and VAS scale for anxiety greater than 10/100 were associated with an increased risk of residual dizziness. The odds ratio were respectively 6.5 (age-residual dizziness, Confidence Interval 95%), 6.5 (duration of vertigo-residual dizziness, Confidence Interval 95%) and 15.5 (anxiety levels-residual dizziness, Confidence Interval 95%). Longer symptom duration before diagnosis was associated with higher anxiety levels. The results underline the necessity for an early and correct diagnosis of BPPV, especially in the elderly.
即使在良性阵发性位置性眩晕 (BPPV) 的复位治疗成功后,仍有部分患者会在一定时间内持续感到头晕。我们研究了一组老年患者中与残余头晕相关的患病率和临床因素。共招募了 60 名 65 岁以上患有特发性 BPPV 的门诊患者;排除标准为之前有过眩晕发作史,包括位置性眩晕。患者使用视觉模拟量表 (VAS) 来描述自己对眩晕的主观焦虑程度,随后进行适当的复位治疗,直到眼震消失。收集有关 BPPV 的人口统计学和临床特征的数据。患者在主观头晕和不平衡感完全消失且无位置性眼震时进行随访。从 BPPV 缓解后的第二天开始收集有关残余头晕的数据。分析与残余头晕相关的临床和人口统计学因素。22 名患者(37%)报告有残余头晕。这些患者的残余头晕平均持续时间为 13.4 ± 7.5 天。残余头晕与性别、受累半规管以及复位治疗次数之间未观察到关联。另一方面,年龄大于 72 岁、症状持续时间大于 9 天以及 VAS 焦虑评分大于 10/100 与残余头晕的风险增加相关。比值比分别为 6.5(年龄-残余头晕,95%置信区间)、6.5(眩晕持续时间-残余头晕,95%置信区间)和 15.5(焦虑水平-残余头晕,95%置信区间)。在诊断前的症状持续时间较长与较高的焦虑水平相关。这些结果强调了早期正确诊断 BPPV 的必要性,尤其是在老年人中。